COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces spike protein-specific neutralizing antibodies associated with protective immunity. The emergence of the B.1.1.7 and B.1.351 variants...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications Vol. 12; no. 1; pp. 3991 - 11
Main Authors: Jalkanen, Pinja, Kolehmainen, Pekka, Häkkinen, Hanni K., Huttunen, Moona, Tähtinen, Paula A., Lundberg, Rickard, Maljanen, Sari, Reinholm, Arttu, Tauriainen, Sisko, Pakkanen, Sari H., Levonen, Iris, Nousiainen, Arttu, Miller, Taru, Välimaa, Hanna, Ivaska, Lauri, Pasternack, Arja, Naves, Rauno, Ritvos, Olli, Österlund, Pamela, Kuivanen, Suvi, Smura, Teemu, Hepojoki, Jussi, Vapalahti, Olli, Lempainen, Johanna, Kakkola, Laura, Kantele, Anu, Julkunen, Ilkka
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 28.06.2021
Nature Publishing Group
Nature Portfolio
Subjects:
ISSN:2041-1723, 2041-1723
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first